Endovia Health (EDVA) stock price, chart and financials
Price chart
Financials
- Revenue (trailing twelve months)
- $32,090.00
- Gross profit (trailing twelve months)
- $25,348.00
- Gross margin
- 78.99%
- Net income (quarter)
- −$2.1M
- Net margin
- −53856.52%
- EPS (trailing twelve months)
- −$22.48
- Book value per share
- −$4.09
- Debt to assets
- 1563.21%
Company profile
Endovia Health Sciences Inc is building a diversified cannabinoid health sciences platform through pharmaceutical innovation, strategic partnerships and disciplined execution. Endovia acquires, develops and commercializes differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets. Endovia's product begins with CannEpil, a cannabinoid pharmaceutical asset, and extends into veterinary development and consumer wellness as the pipeline expands.
Frequently asked questions
Is Endovia Health (EDVA) profitable?
No. Endovia Health reported a net loss of $17.3M over the trailing twelve months.
How much revenue does Endovia Health (EDVA) make?
Endovia Health generated $32,090.00 in revenue over the trailing twelve months.
How do I buy stock in Endovia Health (EDVA)?
EDVA trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.